Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
TREX1 constitutes the major 3'-->5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903 · cited 5×
“3), comparable to the level seen in cells from unaffected heterozygous parents of subjects with recessive AGS.6 Our previous analyses of AGS-affected patients with biallelic TREX1 mutations indicated that AGS at the AGS1 locus results from an abrogation of TREX1 enzyme activity.6 The TREX1 protein functions as a dimer…”
BackgroundSelf-citationOnline Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Crow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Self-citationMutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470 · cited 1×
“Of note in the context of AGS, mutations in DNase I are associated with a lupus phenotype,(22) and mice deficient in DNase II accumulate undigested DNA in macrophages, with consequent IFN-b up-regulation, and recapitulate the clinical and immunological phenotype of rheumatoid arthritis.(23) We have suggested(6) that A…”
BackgroundMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380 · cited 2×
“Lymphoblastoid cell lines were established from affected individuals, and TREX1 exonuclease activity in cell extracts was measured, as described elsewhere, with use of a polydeoxynucleotide substrate.(3) Extracts of control lymphoblastoid cell lines exhibited readily detected TREX1 activity.”
BackgroundMethodSelf-citationMazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citationChowdhury, D., Beresford, P. J., Zhu, P., Zhang, D., Sung, J.-S., Demple, B., Perrino, F. W., & Lieberman, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.005 · Cited by 264
Self-citationA human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein
Hoss, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3868 · Cited by 170 · cited 3×
“Despite its position within the EXO I domain, one of three sequence motifs containing four acidic residues participating in the coordination of divalent metal ions necessary for catalysis—the phenylalanine at position 17—is not conserved in mouse Trex1 or the related human TREX2.”
BackgroundSelf-citation
Cited by
Items 201–300 of 404
Epilepsy in Aicardi–Goutières syndrome
Ramantani, G., Maillard, L. G., Bast, T., Husain, R. A., Niggemann, P., Kohlhase, J., Hertzberg, C., Ungerath, K., Innes, A. M., Walkenhorst, H., et al. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.07.005 · Cited by 23
The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench
Hofer, M. J., Modesti, N. B., Coufal, N. G., Wang, Q., Sase, S., Miner, J. J., Vanderver, A. L., & Bennett, M. L. (2024) · Immunological Reviews · doi:10.1111/imr.13413 · Cited by 26
“Patients with heterozygous pathogenic mutations in TREX1 can present with systemic lupus erythematosus, familial chil-blain lupus, and cryofibrinogenemia, 89,90 including variants also seen in individuals affected by AGS.”
Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
Lai, J., Luo, X., Tian, S., Zhang, X., Huang, S., Wang, H., Li, Q., Cai, S., & Chen, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00088 · Cited by 22
Sugiura, K., Takeichi, T., Kono, M., Ito, Y., Ogawa, Y., Muro, Y., & Akiyama, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.210 · Cited by 22
Yi, C., Li, Q., & Xiao, J. (2020) · Pediatric Rheumatology · doi:10.1186/s12969-020-00423-y · Cited by 22
Nucleic acid metabolism and systemic autoimmunity revisited
Lee‐Kirsch, M. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27372 · Cited by 22
“Third, mutations in the same gene, namely TREX1, are linked to both disorders (4,7,8).”
BackgroundLinthorst, J., Nivard, M. G., & Sistermans, E. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114799 · Cited by 23
Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis
Devarapu, S. K., Lorenz, G., Kulkarni, O. P., Anders, H., & Mulay, S. R. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2016.12.001 · Cited by 21
Leeb, T., Leuthard, F., Jagannathan, V., Kiener, S., Letko, A., Roosje, P. J., Welle, M. M., Gailbreath, K. L., Cannon, A., Линек, М., et al. (2020) · Genes · doi:10.3390/genes11020159 · Cited by 21
“To date, a single monogenic form of CLE caused by heterozygous variants in the TREX1 gene encoding the three prime repair exonuclease has been identified in human patients with familial chilblain lupus erythematosus [12].”
BackgroundType-I Interferon Signaling in Fanconi Anemia
Landelouci, K., Sinha, S., & Pépin, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.820273 · Cited by 23
Chromatin bridges: stochastic breakage or regulated resolution?
Jiang, H., & Chan, Y. W. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.10.004 · Cited by 24
Muñoz, J. D. Z., Marque, M., Dandurand, M., Meunier, L., Crow, Y. J., & Bessis, D. (2015) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2015.06.018 · Cited by 20
Self-citationCell‐free nucleic acids are present in blood products and regulate genes of innate immune response
Abramowski, S. W., Tirefort, D., Lau, P., Guichebaron, A., Taleb, S., Modoux, C., Lemoine-Chaduc, C., Bruyère‐Cerdan, P., Lombard, P. R., Lecompte, T., et al. (2018) · Transfusion · doi:10.1111/trf.14613 · Cited by 20
“Similarly, loss of function mutations in the Trex1 endonuclease have been reported in several autoimmune diseases, resulting in increased levels of extracellular DNA and systemic autoimmunity.(10,13,14) Moreover, there is growing evidence that receptors for human nucleic acids could trigger interferon production and c…”
BackgroundExonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer
Manils, J., Marruecos, L., & Soler, C. (2022) · Cells · doi:10.3390/cells11142157 · Cited by 24
“Exonucleases like TREX1 in the cytosol and PLD3 and PLD4 in the endolysosomes regulate cytosolic cGAS/STING activation and endosomal TLR nucleic acid-sensing, respectively [26,27], thereby limiting DNA-driven autoimmune diseases, such as rheumatoid arthritis and lupus [28,29].”
BackgroundDesignation of Autoinflammatory Skin Manifestations With Specific Genetic Backgrounds
Kanazawa, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00475 · Cited by 19
“Among chilblain lupus patients, familial occurrence is present and heterozygous mutations in TREX1 (14), SAMHD1, and STING1 have been identified to be responsible.”
BackgroundInfluentialActivation of type I interferon in systemic lupus erythematosus
Kirou, K. A., Mavragani, C. P., & Crow, M. K. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.579 · Cited by 20
The neurovascular unit in leukodystrophies: towards solving the puzzle
Zarekiani, P., Pinto, H. N., Hol, E. M., Bugiani, M., & de Vries, H. E. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00316-0 · Cited by 20
‘From R-lupus to cancer’: Reviewing the role of R-loops in innate immune responses
Bradley, L., & Savage, K. I. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103581 · Cited by 19
“Mutations in RNASEH2 and TREX1 have also been reported in the autoimmune diseases, systemic lupus erythematosus (SLE) and Familial Chilblain Lupus (FCL) [50 – 52], whilst SAMHD1 mutations have been shown to induce an enrichment of R-loops [53].”
The importance of chilblains as a diagnostic clue for mild Aicardi–Goutières syndrome
Yarbrough, K. B., Danko, C., Krol, A. L., Zonana, J., & Leitenberger, S. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37944 · Cited by 17
DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity
Manolakou, T., Verginis, P., & Boumpas, D. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115842 · Cited by 23
Perrino, F. W., de Silva, U., Harvey, S. E., Pryor, E. E., Cole, D. W., & Hollis, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803629200 · Cited by 17
Self-citationLung involvement in monogenic interferonopathies
Cazzato, S., Omenetti, A., Ravaglia, C., & Poletti, V. E. (2020) · European Respiratory Review · doi:10.1183/16000617.0001-2020 · Cited by 21
Pathology of the neurovascular unit in leukodystrophies
Zarekiani, P., Breur, M., Wolf, N. I., de Vries, H. E., van der Knaap, M. S., & Bugiani, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01206-6 · Cited by 17
“Aicardi-Goutiéres syndrome (AGS) is another astrocytopathy [53].”
Arthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05632-4 · Cited by 16
DNA binding induces active site conformational change in the human TREX2 3'-exonuclease
de Silva, U., Perrino, F. W., & Hollis, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp025 · Cited by 20
Self-citationGeneral Features of Autoimmune Disease
Davidson, A., & Diamond, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00003-8 · Cited by 22
Immune sensing of nucleic acids in inflammatory skin diseases
Demaria, O., Domizio, J. D., & Gilliet, M. F. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0445-5 · Cited by 18
Modes of Retrotransposition of Long Interspersed Element-1 by Environmental Factors
Ishizaka, Y., Okudaira, N., Tamura, M., Iijima, K., Shimura, M., Goto, M., & Okamura, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00191 · Cited by 16
Recognize Yourself—Innate Sensing of Non-LTR Retrotransposons
Lagisquet, J., Zuber, K., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13010094 · Cited by 20
“Interestingly, in some cases of SLE, TREX1 deficiency has been linked to the disease, suggesting a similar mechanism of triggering autoimmune responses in SLE and AGS [55,56].”
BackgroundThe Genetic Landscape of Cutaneous Lupus Erythematosus
Chen, H. W., Barber, G., & Chong, B. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.916011 · Cited by 16
“Another case report of a family with familial chilblain lupus revealed that three affected individuals all carried the same heterozygous mutation (19).”
BackgroundSrivastava, S., Koch, L. K., & Campbell, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401039 · Cited by 17
The capillaroscopic findings in idiopathic pernio: is it a microvascular disease?
Ozmen, M., Kurtoglu, V., Can, G., Tarhan, E. F., Soysal, D., & Aslan, S. L. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0768-9 · Cited by 15
Fye, J. M., Coffin, S. R., Orebaugh, C. D., Hollis, T., & Perrino, F. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559252 · Cited by 17
Self-citationHow SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest
Blondot, M.-L., Dragin, L., Lahouassa, H., & Margottin-Goguet, F. (2014) · Retrovirology · doi:10.1186/preaccept-2057766064124418 · Cited by 19
Lamas, A., Faria, R., Marinho, A., & Vasconcelos, C. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103675 · Cited by 17
Deng, Y., & Tsao, B. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00005-0 · Cited by 16
Skeldon, A. M., Wang, L., Sgarioto, N., Beveridge, R. E., Chan, S. Y. T., Dorich, S., Dumais, V., Fradet, N., Gaudreault, S., LeGros, P., et al. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01481-7 · Cited by 15
Aicardi-Goutières Syndrome: Cutaneous, Laboratory, and Radiologic Findings: A Case Report
Juern, A. M., Robbins, A. C., Galbraith, S. S., & Drolet, B. A. (2010) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.01055.x · Cited by 13
“The findings are most often localized to the extremities, and sometimes the earlobes andareworst in the winter months (1,2,12,13).”
BackgroundTREX1 exonuclease in immunity and disease
Shang, Z., Wang, L., & Zhou, W. (2025) · International Immunology · doi:10.1093/intimm/dxaf037 · Cited by 16
Aicardi-Goutières syndrome with emphasis on sonographic features in infancy
Rößler, L., Ludwig-Seibold, C., Thiels, C., & Schaper, J. (2012) · Pediatric Radiology · doi:10.1007/s00247-012-2384-4 · Cited by 12
Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus
Miyagawa, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030987 · Cited by 12
“The identified mutation in TREX1 caused reduced exonucleolytic activity [57,58], which can lead to the impairment of granzyme A-mediated caspase-independent apoptosis [58].”
BackgroundType I Interferonopathies in Childhood
Haşlak, F., Könte, E. K., Aslan, E., Şahin, S., & Kasapçopur, Ö. (2023) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2023.2023-4-78 · Cited by 16
Agrawal, R., Tarannum, N., Chourasia, M., & Soni, R. K. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-017-0987-4 · Cited by 12
Type I Interferon Induction in Cutaneous DNA Damage Syndromes
Klein, B., & Günther, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715723 · Cited by 16
“Loss of function mutations of TREX1, which were originally described in AGS (Aicardi Goutieres syndrome), result in accumulation of cytosolic DNA inducing a cGAS-dependent type I IFN secretion (37, 38).”
BackgroundIntracellular Sensing of DNA in Autoinflammation and Autoimmunity
MacLauchlan, S., Fitzgerald, K. A., & Gravallese, E. M. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42256 · Cited by 13
“Other studies have shown that sera from SLE patients strongly evoke an IFN response in macrophages, a phenomenon proposed to be due to the presence of DNA in apoptotic microvessels (67).”
BackgroundInfluentialWang, B. X., Grover, S. A., Kannus, P., Yoon, G., Laxer, R. M., Yeh, E. A., & Fish, E. N. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0117 · Cited by 15
Exploring emerging JAK inhibitors in the treatment of Aicardi–Goutières syndrome
Politano, D., Tonduti, D., Battini, R., Fazzi, E. M., & Orcesi, S. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2445508 · Cited by 12
Blueberry Muffin Rash as the Presenting Sign of Aicardi–Goutières Syndrome
Brisman, S., González, M. E., & Morel, K. D. (2009) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.00947.x · Cited by 11
“aberrant immune system given the phenotypic and genotypic overlap of AGS and some forms of lupus (8), elevated IFN-a levels in the CSF and serum, and the observationof sterile pyrexias, polygammaglobulinemia, and Coombs positive hemolytic anemia in some patients (7).”
BackgroundSkin Disease in Cutaneous Lupus Erythematosus
Chong, B. F., & Werth, V. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00033-5 · Cited by 11
Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment
Natoli, V., Charras, A., Smith, E. M. D., & Hedrich, C. M. (2025) · Current Rheumatology Reports · doi:10.1007/s11926-025-01207-7 · Cited by 12
“For example, loss-of-function variants affecting the 3’−5’ exonuclease TREX1 ( DNAse3 ) associate with familial chilblain lupus, early-onset SLE, and in AGS [ 57– 59 ].”
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling
Shim, A., Luan, X., Zhou, W., Crow, Y. J., & Maciejowski, J. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae089 · Cited by 10
“AGS can result from loss-of-function (or specific dominant-negative) mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR1, gain-of-function mutations in IFIH1 (2,3).”
Self-citationJung, C. H., Lee, Y. J., Cho, E. H., Lee, G. E., Kim, S. T., Sung, K. S., Kim, D.-H., Kim, D. H., Son, Y. S., Ahn, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115094 · Cited by 11
Liu, Y., Li, Y., Xue, L., Xiao, J., Li, P., Xue, W., Li, C., Guo, H., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033982 · Cited by 12
“IFN-1 is an important link in the progression of SLE and is secreted mainly by dendritic cells and plasma cells (Murayama et al., 2020; Thim-Uam et al., 2020).”
BackgroundJorge, M. S., & Bugiani, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_9 · Cited by 11
Rutherford, H. A., Kasher, P. R., & Hamilton, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623650 · Cited by 12
Interferon-Alpha in Systemic Lupus Erythematosus
Crow, M. K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10018-x · Cited by 11
Nucleic Acid Sensing in the Tumor Vasculature
Baris, A. M., Fraile‐Bethencourt, E., & Anand, S. (2021) · Cancers · doi:10.3390/cancers13174452 · Cited by 10
Bélot, A., Tusseau, M., Cognard, J., Georgin‐Lavialle, S., Boursier, G., & Hedrich, C. M. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70003 · Cited by 9
Gilbert, M., & Punaro, M. (2014) · Pediatric Rheumatology · doi:10.1186/1546-0096-12-16 · Cited by 8
“Mutation in TREX1 is also associated with familial chilblain lupus, which is a nodular form of cutaneous lupus [47].”
BackgroundSun, X., Chao, J. L., Gerner, M. Y., & Elkon, K. B. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43108 · Cited by 8
Interactions Between HIV-1 and Innate Immunity in Dendritic Cells
Silvin, A., & Manel, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_7 · Cited by 12
Solving the genetic puzzle of systemic lupus erythematosus
Yang, W., & Lau, Y. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2947-8 · Cited by 8
“mutations inDNASE1 [48], TREX1 [50, 74], andC1q,C2, and C4 [47], which cause Mendelian types of SLE, do lend support to this notion.”
BackgroundInfluentialIdiopathic connective tissue disorders
Luzar, B., & Calonje, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-5649-2.00017-2 · Cited by 8
Macaron, G., Khoury, J., Hajj‐Ali, R. A., Prayson, R. A., Srivastava, S. K., Ehlers, J. P., Mamsa, H., Liszewski, M. K., Jen, J. C., Bermel, R. A., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103015 · Cited by 8
Vasculitis and vasculopathy associated with inborn errors of immunity: an overview
Federici, S., Cinicola, B. L., Torre, F. L., Castagnoli, R., Lougaris, V., Giardino, G., Volpi, S., Caorsi, R., Leonardi, L., Corrente, S., et al. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1258301 · Cited by 11
“…by infantile-onset neurologic manifestations, including encephalopathy with basal ganglia calci fi cations and white matter lesions, cerebrospinal lymphocytosis mimicking congenital viral infections, and progressive neurologic involvement (128) associated with chilblain-like lesions (127, 129, 130).”
BackgroundPandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection
Arkin, L. M., Costa-da-Silva, A. C., Frere, J. J., Ng, A., Sharma, R., Moon, J. J., Bussan, H. E., Kim, C. H., Javaid, A., Steidl, O., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110525 · Cited by 7
“11,12 16 Following the first reports in March 2020 of otherwise healthyindividuals,manyof themchildren,withpernio andfewextracutaneous symptomsor signsof COVID-19,pandemic-associatedpernio (herein referred to as PAP) was widely reported across Europe and the United States, 17–21 where it was quickly…”
Skin Disease in Cutaneous Lupus Erythematosus
Chong, B. F., & Werth, V. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00024-8 · Cited by 7
Etiology and Pathogenesis of Systemic Lupus Erythematosus
Crow, M. K. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00079-7 · Cited by 13
Zhi, Y., Liu, J., Kuang, P., Zhang, X., Xu, Z., Chen, Y., Lin, X., Wu, X., Zhou, P., & Chen, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114988 · Cited by 9
Genetik des Lupus erythematodes
Günther, C. (2015) · Der Hautarzt · doi:10.1007/s00105-014-3570-0 · Cited by 7
Cytokines and Interferons in Lupus
Crow, M. K., Niewold, T. B., & Kirou, K. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00007-8 · Cited by 7
Xie, N., Sun, Q., Yang, J., Zhou, Y., Xu, H., Zhou, Y., & Zhou, Y. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01712-9 · Cited by 8
The Sixth Sense: Self-nucleic acid sensing in the brain
Dorrity, T. J., Shin, H., Gertie, J. A., & Chung, H. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.03.001 · Cited by 6
Two rare mutations in homozygosity synergize to silence TREX1 in Aicardi-Goutières syndrome
Rubin, T. S., Bernier, S., Lim, L. S. H., Salman, M. S., Leung, E., Mhanni, A. A., Marles, S. L., Greenberg, C. R., Perez, A., Sun, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557632 · Cited by 8
Gagne, S. J., Sivaraman, V., & Akoghlanian, S. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1169638 · Cited by 6
“Similar to non-Mendelian SLE, autoantibodies can be present in monogenic SLE and AGS, along with cytopenias (e.g., anemia and thrombocytopenia) and elevated transaminases.”
BackgroundInfluentialEndo, Y., Koga, T., Otaki, H., Furukawa, K., & Kawakami, A. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108732 · Cited by 6
Migraine and Neurogenetic Disorders
Sathe, S. A. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0360-9 · Cited by 6
Familiärer Chilblain-Lupus: Typ-I-Interferonopathie mit Modellcharakter
Fiehn, C. (2017) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-017-0285-5 · Cited by 6
Cutaneous manifestations of pediatric lupus
Arkin, L. M., Nguyen, C., & Klein‐Gitelman, M. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000610 · Cited by 8
“Mutations in the TREX1 and SAMHD1 genes are also known to cause Aicardi–Goutières syndrome, which is an autoinflammatory syndrome characterized by early-onset encephalopathy, increased levels of IFN-a, chilblain lupus, antinuclear antibodies and arthritis [53,56].”
BackgroundHIV suppressors against LINE-1: one functions as two
Du, J., & Zhao, K. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1893640 · Cited by 7
“However, it was later determined that some of these AGS-associated TREX1 mutants retain ssDNA digestion activity (Rice et al. 2007), suggesting that exonuclease activity might not be the mechanism of TREX1-mediated LINE-1 suppression.”
BackgroundTrakadis, Y. J., Accogli, A., Qi, B., Bloom, D., Joober, R., Levy, E., & Tabbane, K. (2021) · Neurogenetics · doi:10.1007/s10048-021-00664-3 · Cited by 8
Lupus-engelures familial : quatre cas sur trois générations
Beltoise, A.-S., Audouin-Pajot, C., Lucas, P., Tournier, É., Rice, G., Crow, Y. J., & Mazereeuw‐Hautier, J. (2018) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2018.07.014 · Cited by 7
Self-citationIzzotti, A., Longobardi, M., Cartiglia, C., Anzuini, F., Arrigo, P., Fazzi, E. M., Orcesi, S., Piana, R. L., & Pulliero, A. (2011) · Journal of Child Neurology · doi:10.1177/0883073811413582 · Cited by 6
“Observed Aicardi-Goutières syndrome mutation frequencies were in line with previously reported studies,(2,4) and the occurrence of the OTHER status probably reflected the lack of further gene discovery.(3,4) It is likely that these genes include the recently discovered Aicardi-Goutières syndrome 5 genetic locus affect…”
MethodResultØstergaard, E., Joensen, F., Sundberg, K., Dunø, M., Hansen, F. J., Batbayli, M., Sørensen, N., & Born, A. P. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02807.x · Cited by 6
“autosomal dominant inheritance has been described in a few cases (4,5).”
BackgroundGenetic and Metabolic Disorders of the White Matter
Vanderver, A. L., & Wolf, N. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00071-8 · Cited by 7
ER-tethering directs TREX1 penetration of a BAF-dependent barrier at micronuclei
Chen, Y., Norman, R. M., Toufektchan, E., Luan, X., Shim, A., Rosenberg, H., Kovacs, M. T., Nichols, A., Hickling, J. H., Cifani, P., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.02.012 · Cited by 8
Chauvin, S. D., Holley, J. A., Poddar, S., Miner, C. A., Kumble, L., Fu, J., Laue-Gizzi, H., Hardy, T. A., & Miner, J. J. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01846-y · Cited by 5
Family History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome
Schmidt, J., Olivieri, I., Vento, J. M., Fazzi, E. M., Gordish‐Dressman, H., Orcesi, S., & Vanderver, A. L. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/206730 · Cited by 6
A synonymous variant in TREX1 is associated with systemic sclerosis and severe digital ischaemia
Hughes, M., Little, J., Herrick, A. L., Pushpakom, S. P., Byers, H., Worthington, J., & Newman, W. G. (2016) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2016.1195872 · Cited by 5
“Biallelic mutations in TREX1 have been identified in Aicardi–Goutières syndrome (a neurodevelopmental disorder characterized by progressive encephalopathy) (2) and rare heterozygous variants in familial chilblain lupus (3) and autoimmune diseases including systemic lupus erythematous (4) and SSc (5).”
BackgroundSelf-citationClassification, pathology, and basic aspects
Pantoni, L., & Gorelick, P. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.002 · Cited by 5
A TREX1 model reveals double-strand DNA preference and inter-protomer regulationPreprint
Hemphill, W. O., Hollis, T., Salsbury, F. R., & Perrino, F. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.481063 · Cited by 5
“D200H mutations exhibit dominant disease genetics in vivo (2, 11), and the recombinant TREX1D18N, TREX1D18H, TREX1D200N, and TREX1D200H enzymes recapitulate these dominant biochemical properties during dsDNA degradation of plasmid and chromatin DNA in vitro (11–13).”
BackgroundSelf-citationConcepts in lupus pathophysiology: Lessons learned from disease across the spectrum
Lo, M. S. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109021 · Cited by 4
Queiroz, M. A. F., Moura, T. C. F., Bichara, C. D. A., de Lima, L. L. P., de Oliveira, A. Q. T., de Souza, R. G., Gomes, S. T. M., Amoras, E. D. S. G., & Vallinoto, A. C. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119660 · Cited by 4
Werth, V. P., Vera‐Kellet, C., & Dutz, J. P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10041-5 · Cited by 4
Özcan, D., Serbes, M., Ekinci, R. M. K., Balcı, S., Şaşihüseyinoğlu, A. Ş., Bişgin, A., & Altıntaş, D. U. (2021) · Allergologia et Immunopathologia · doi:10.15586/aei.v49i6.450 · Cited by 4
Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J., Su, Z.-H., Han, Q., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X., Chen, X., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-023-00777-6 · Cited by 5
Superficial and deep perivascular inflammatory dermatoses
Calonje, E. J., Brenn, T., & Lazar, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-5649-2.00008-1 · Cited by 4
Genetic and Metabolic Disorders of the White Matter
Vanderver, A. L., & Wolf, N. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00099-0 · Cited by 6
Goodfield, M. J. D., Dutz, J. P., & McCourt, C. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0052 · Cited by 5
Cladophorol-A is an inhibitor of cyclic GMP-AMP synthase
Kissai, M., Chin, E. N., Martínez‐Peña, F., Sulpizio, A., Stout, E. P., Usui, I., Barmare, F., Sanchez, B. B., Esquenazi, E., Stanfield, R. L., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.130007 · Cited by 3
Metadata
- Authors
- Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., Herrick, A. L., Bowden, A. P., Perrino, F. W., Lindahl, T., Barnes, D. E., & Crow, Y. J.
- Affiliations
- St James's University Hospital (GB)
- St Mary's Hospital (GB)
- National Health Service (GB)
- Cancer Research UK (GB)
- Wake Forest University Health Sciences (US)
- Royal Aberdeen Children's Hospital (GB)
- Salford Royal Hospital (GB)
- Rochdale Infirmary (GB)
- Corresponding author
- Crow, Yanick J.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 80
- Issue
- 4
- Pages
- 811-815
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1852703
- OpenAlex
- W2171946670
- Cited by
- 410
- References
- 24
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 37 · 2023: 13 · 2022: 22 · 2021: 31 · 2020: 19 · 2019: 17 · 2018: 15 · 2017: 20 · 2016: 19 · 2015: 25 · 2014: 26 · 2013: 31 · 2012: 28
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2301 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TREX1, chilblain lupus, Aicardi-Goutières syndrome, heterozygous mutation, de novo mutations, 3'-5' exonuclease, systemic lupus erythematosus, autoinflammatory disease, catalytic residues
- MeSH terms
- Basal Ganglia Diseases, Base Sequence, Cell Line, Exodeoxyribonucleases, Female, Humans, Lupus Erythematosus, Systemic, Male, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Syndrome, Sequence Analysis, DNA, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.